Navigation Links
Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Date:10/31/2007

SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 6, 2007 at 12:20 p.m. Eastern Time (9:20 a.m. Pacific Time) at the New York Palace Hotel in New York City. Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, is scheduled to provide a corporate overview of the company and its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation fo
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...A, Md., Nov. 19 Spherix ...technology for diabetes therapy, and a provider of...ood, supplement, biotechnology and pharmaceutical ...y reported $6.3 million registered direct placemen...f its common stock and warrants to purchase up to ...
(Date:11/19/2009)...PRNewswire/ - Aegera Therapeutics Inc. announced t...ed Phase 2B study of AEG35156, a targeted antisens...e oncology indications. ,, The study, entitled ...inked Inhibitor of Apoptosis (XIAP) Antisense AEG3...e and Idarubicin in AML Following Failure of a Sin...
(Date:11/18/2009)...18 Marrone Bio Innovations (MBI), ...ialization of effective and environmentally respon...has been named an IC20 company by the Investors, C...nal angel investing group. ,, Companies named t...ng results for all stakeholders, including investo...
(Date:11/18/2009)...Nov. 18 Sangamo BioScien...ta from the University of Pennsylvania investigato... finger nuclease (ZFN) based product, SB-728-T, fo...losed on the internet. ,, Data were presented i...ia School of Medicine from a single subject treate...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
..., Calif., Dec. 16 Neurobiological,Technologies, I...t Celtic,Pharmaceutical Holdings L.P. (Celtic) has...ld the worldwide rights and assets related to XERE...o receive milestone payments upon the,achievement ...s approved for,commercial sale, NTI is also entitl...
...Mass.Dec. 16 NxStage Medical, Inc. (Nasdaq: NXT... products, today announced that Jeffrey H. Burbank...Financial Officer, will be presenting at the JPMor..., 2009 at the Westin St. Francis Hotel in San Fran... scheduled for Wednesday, January 14th at 4:30 p.m...
... Forum Attendees to Keep up Fight, Restore U.S.,s ...lvania,s commitment to developing and diversifying...o weather the economic downturn and set the stage ...ward G. Rendell said today. , , "In Pennsylva...ovation economy, and we are working hard to take a...
Other Biology Technology:Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 2Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 3Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 4NxStage to Present at the JPMorgan Healthcare Conference 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 3
(Date:11/20/2009)...2009) Scientists from the Marine Biogeochemistry ...esearch Laboratory (NRL) organized and led a team ...ic expedition to initiate methane hydrate explorat...variation of sediment contribution to Arctic clima...er Polar Sea as a research platform, three cross-s...
(Date:11/20/2009)...ingle bacterial gene into yeast, researchers from ...achieved three improvements in bioethanol producti..., less acetate and elimination of the major by-pro...ed in the scientific journal Applied and Environm... is made by the yeast Saccharomyces cerevisiae fro...
(Date:11/20/2009)...y disease (COPD), a respiratory disease commonly k...urth leading cause of death worldwide. 600 millio... yet to find any real treatment or cure, Grace Par...ty of Western Ontario in London, Canada, is using ...o the disease. , Parraga is a scientist in t...
Breaking Biology News(10 mins):International expedition investigates climate change, alternative fuels in Arctic 2Delft breakthrough in bioethanol production from agricultural waste 2Gaining a better picture of lung disease 2Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 1MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 2MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 3MedSolutions 3A Accurate Diagnosis Is Critical to Reducing Healthcare Costs 47688 417 Million U S Children Live More Than an Hour Away From Trauma Care 47684 117 Million U S Children Live More Than an Hour Away From Trauma Care 47684 217 Million U S Children Live More Than an Hour Away From Trauma Care 47684 3
...cials around the world keep a nervous eye on the s...chewan,s Vaccine and Infectious Disease Organizati...uenza virus causes infection. , Yan Zhou and her t...ports the influenza A virus,s ability to reproduce...e way for new drugs and vaccines. , The paper ...
...ing at Cornell University in Ithaca and Weill Corn...ed a panel of 23 protein biomarkers in cerebrospin...," which doctors might use someday to identify pat...rch will be published in the December online-editi...now, physicians rely on their clinical judgment to...
...n bacteria in the Earth, Shewanella oneidensis MR-.... But in the absence of oxygen, Shewanella uses (o...lso have adsorbed heavy metals on them. As a resul...bility of iron and environmental contaminants like...yaditya Bose and Professor Michael Hochella Jr., b...
Other Biology News:U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 3Particle size matters to bacteria ability to immobilize heavy metals 2Particle size matters to bacteria ability to immobilize heavy metals 3
...denses and traps a wide variety of solvent vapors ...Easy-to-use glass condensation flask (GCF400) allo...ned jar for easy draining. Rapid cooling time mini...ask for quick solvent changes , -50?C Temeratu...
Lambda Protein Phosphatase from New England Biolabs
Shrimp Phosphatase, Alkaline, Unconjugated from Sigma-Aldrich
...high performance spectral scanning multimode reade...advanced SkanIt Software it offers superior flexib...elopment. Varioskan provides unlimited wavelength ...d fluorescence and photometric assays and a dispen...
Biology Products: